Vaccination of Children Following Allogeneic Stem Cell Transplantation

Allogeneic Haematopoietic Stem Cell Transplantation Clinical Trial

Official title:
Immunogenicity of the DTaP-IPV-HBV/Hib Combination Vaccine Infanrix Hexa and the Heptavalent Pneumococcal Conjugate Vaccine Prevenar in Pediatric Recipients of Allogeneic Haematopoietic Stem Cell Transplantation

Status Completed

Clinical Trial Summary

The purpose of this study is to determine the immunogenicity and tolerability of the DTaP-IPV-HBV/Hib combination vaccine Infanrix hexa and the heptavalent pneumococcal conjugate vaccine Prevenar in pediatric recipients of allogeneic haematopoietic stem cell transplantation.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

Allogeneic Haematopoietic Stem Cell Transplantation

Clinical Trial Details

NCT number	NCT00169728
Study type	Interventional
Source	Heinrich-Heine University, Duesseldorf
Contact
Status	Completed
Phase	Phase 3
Start date	September 2003
Completion date	October 2006

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT00990249` - Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation	Phase 2
	Completed	`NCT02048800` - Treosulfan Pharmacokinetics in Children Undergoing Allogeneic HSCT